• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.45% Nasdaq Up0.40%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    5.41 Down 0.27(4.75%) 4:00PM EDT
    |After Hours : 5.45 Up 0.04 (0.74%) 5:09PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 678   767   123  
    Cost of Revenue365  333  108  
    Gross Profit 313   434   15  
    Operating Expenses
    Research Development24,964  19,985  10,925  
    Selling General and Administrative19,819  17,938  8,572  
    Non Recurring43,482  2,229  1  
    Others1,544  1,891  298  
    Total Operating Expenses89,809  42,043  19,796  
    Operating Income or Loss (89,496) (41,609) (19,781)
    Income from Continuing Operations
    Total Other Income/Expenses Net5,329  2,410  553  
    Earnings Before Interest And Taxes(84,167)(39,199)(19,228)
    Interest Expense1,585  1,060  432  
    Income Before Tax(85,752)(40,259)(19,660)
    Income Tax Expense(1,698)(1,443)(12,722)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(84,054)(38,816)(6,938)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (84,054) (38,816) (6,938)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (84,054) (38,816) (6,938)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.